Colombo T - Search Results

1

The combination of yondelis and cisplatin is synergistic against human tumor xenografts.

D'Incalci M, Colombo T, Ubezio P, Nicoletti I, Giavazzi R, Erba E, Ferrarese L, Meco D, Riccardi R, Sessa C, Cavallini E, Jimeno J, Faircloth GT. D'Incalci M, et al. Among authors: colombo t. Eur J Cancer. 2003 Sep;39(13):1920-6. doi: 10.1016/s0959-8049(03)00490-8. Eur J Cancer. 2003. PMID: 12932672

2

Effective combination of ET-743 and doxorubicin in sarcoma: preclinical studies.

Meco D, Colombo T, Ubezio P, Zucchetti M, Zaffaroni M, Riccardi A, Faircloth G, Jose J, D'Incalci M, Riccardi R. Meco D, et al. Among authors: colombo t. Cancer Chemother Pharmacol. 2003 Aug;52(2):131-8. doi: 10.1007/s00280-003-0636-6. Epub 2003 May 29. Cancer Chemother Pharmacol. 2003. PMID: 12783202

3

Complete protection by high-dose dexamethasone against the hepatotoxicity of the novel antitumor drug yondelis (ET-743) in the rat.

Donald S, Verschoyle RD, Greaves P, Gant TW, Colombo T, Zaffaroni M, Frapolli R, Zucchetti M, D'Incalci M, Meco D, Riccardi R, Lopez-Lazaro L, Jimeno J, Gescher AJ. Donald S, et al. Among authors: colombo t. Cancer Res. 2003 Sep 15;63(18):5902-8. Cancer Res. 2003. PMID: 14522916

4

The combination of the tyrosine kinase receptor inhibitor SU6668 with paclitaxel affects ascites formation and tumor spread in ovarian carcinoma xenografts growing orthotopically.

Garofalo A, Naumova E, Manenti L, Ghilardi C, Ghisleni G, Caniatti M, Colombo T, Cherrington JM, Scanziani E, Nicoletti MI, Giavazzi R. Garofalo A, et al. Among authors: colombo t. Clin Cancer Res. 2003 Aug 15;9(9):3476-85. Clin Cancer Res. 2003. PMID: 12960140

5

Distribution and activity of doxorubicin combined with SDZ PSC 833 in mice with P388 and P388/DOX leukaemia.

Colombo T, Gonzalez Paz O, D'Incalci M. Colombo T, et al. Br J Cancer. 1996 Apr;73(7):866-71. doi: 10.1038/bjc.1996.154. Br J Cancer. 1996. PMID: 8611397 Free PMC article.

6

IDN5109, a taxane with oral bioavailability and potent antitumor activity.

Nicoletti MI, Colombo T, Rossi C, Monardo C, Stura S, Zucchetti M, Riva A, Morazzoni P, Donati MB, Bombardelli E, D'Incalci M, Giavazzi R. Nicoletti MI, et al. Among authors: colombo t. Cancer Res. 2000 Feb 15;60(4):842-6. Cancer Res. 2000. PMID: 10706091

7

Cisplatin-induced peripheral neuropathy: neuroprotection by erythropoietin without affecting tumour growth.

Bianchi R, Gilardini A, Rodriguez-Menendez V, Oggioni N, Canta A, Colombo T, De Michele G, Martone S, Sfacteria A, Piedemonte G, Grasso G, Beccaglia P, Ghezzi P, D'Incalci M, Lauria G, Cavaletti G. Bianchi R, et al. Among authors: colombo t. Eur J Cancer. 2007 Mar;43(4):710-7. doi: 10.1016/j.ejca.2006.09.028. Epub 2007 Jan 23. Eur J Cancer. 2007. PMID: 17251006

8

Lymphokine-activated killer (LAK) and monocyte-mediated cytotoxicity on tumor cell lines resistant to antitumor agents.

Allavena P, Damia G, Colombo T, Maggioni D, D'Incalci M, Mantovani A. Allavena P, et al. Among authors: colombo t. Cell Immunol. 1989 Apr 15;120(1):250-8. doi: 10.1016/0008-8749(89)90192-5. Cell Immunol. 1989. PMID: 2784721

9

Cyclosporin A markedly changes the distribution of doxorubicin in mice and rats.

Colombo T, Zucchetti M, D'Incalci M. Colombo T, et al. J Pharmacol Exp Ther. 1994 Apr;269(1):22-7. J Pharmacol Exp Ther. 1994. PMID: 8169829

10

Taxoids in combination with anthracyclines and other agents: pharmacokinetic considerations.

D'Incalci M, Schüller J, Colombo T, Zucchetti M, Riva A. D'Incalci M, et al. Among authors: colombo t. Semin Oncol. 1998 Dec;25(6 Suppl 13):16-20. Semin Oncol. 1998. PMID: 9865687

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

511 results

Search Page

Filters